Clinical trial

New Generation IGRA in Immunocompromised Individuals

NCT02639936

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-12-01

PhaseN/A

Study timeline

Study start (actual)2015-12-01Date precision: month

Registry last updated2025-04-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Monitoring, Immunologicunresolved

Active Tuberculosisunresolved

Tuberculosis in Solid Organ Transplant Recipientsunresolved

Tuberculosis in Marrow Transplant Recipientsunresolved

Tuberculosis in Rheumatoid Arthritisunresolved

Tuberculosis in Chronic Renal Failureunresolved

Tuberculosis in HIV-infected Individualsunresolved

Interventions

Sponsors & collaborators

Tuberculosis Network European Trialsgrouplead sponsor

Mapped research locations

BarcelonaSpain1 LondonUnited Kingdom1 MilanItaly1 WarsawPoland1 CopenhagenDenmark1 OsloNorway1 RomeItaly1 Freiburg im BreisgauGermany1 BresciaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02639936 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.